Harvoni Tablet, Film Coated
Pricing Report NDC 61958-1801-1

View Wholesale Price per Unit, Acquisition Costs, and Historic Pricing Trends

Current Package Pricing Information

The latest wholesale acquisition cost for Harvoni (NDC 61958-1801-1) is $1098.93750 per EA. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Mar 21, 2018.

As a a human prescription drug provided by Gilead Sciences, Inc, this medication is distributed in a 28 TABLET, FILM COATED in 1 BOTTLE, PLASTIC configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$1,098.93750
Per EA

Effective Date
Mar 21, 2018
Billable Units
28 EA
Estimated Package Price
$30,770.25
Data Status
As of Mar 13, 2019
C/I - Chain or Independent Pharmacy
Package NDC
Description
28 TABLET, FILM COATED in 1 BOTTLE, PLASTIC
Pricing Methodology Explanation
The NADAC was carried forward from the previous file.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Jan 2015, the NADAC wholesale price for (NDC ) has moved within a range of $1,084.63500 to $1,101.18095 per EA. Over this 3 years and 2 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$1,084.6350 - $1,101.1810
Market Volatility
1.53% Variance
Latest Trend
0.20%
Date Unit Price Unit Source Method Rate
Mar 21, 2018 $1098.93750 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Mar 21, 2018 $1098.93750 EAC/I - Chain or Independent PharmacyCode 4B - Brand
Nov 08, 2017 $1096.73438 EAC/I - Chain or Independent PharmacyCode 2B - Brand
Nov 08, 2017 $1096.73438 EAC/I - Chain or Independent PharmacyCode 3B - Brand
Nov 08, 2017 $1096.73438 EAC/I - Chain or Independent PharmacyCode 4B - Brand
Oct 18, 2017 $1084.63500 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Aug 23, 2017 $1101.18095 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Aug 23, 2017 $1101.18095 EAC/I - Chain or Independent PharmacyCode 4B - Brand
Nov 02, 2016 $1090.34978 EAC/I - Chain or Independent PharmacyCode 2B - Brand
Nov 02, 2016 $1090.34978 EAC/I - Chain or Independent PharmacyCode 3B - Brand
Nov 02, 2016 $1090.34978 EAC/I - Chain or Independent PharmacyCode 4B - Brand
Aug 17, 2016 $1085.80000 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Aug 17, 2016 $1085.80000 EAC/I - Chain or Independent PharmacyCode 2B - Brand
Oct 21, 2015 $1096.19063 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Oct 21, 2015 $1096.19063 EAC/I - Chain or Independent PharmacyCode 2B - Brand
Jan 21, 2015 $1091.23125 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Jan 21, 2015 $1091.23125 EAC/I - Chain or Independent PharmacyCode 2B - Brand
Jan 21, 2015 $1091.23125 EAC/I - Chain or Independent PharmacyCode 4B - Brand

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 2: The average acquisition cost of the most recent survey was within ± 2% of the current NADAC; therefore, the NADAC was carried forward from the previous file.
  • Code 3: The NADAC based on survey data has been adjusted to reflect changes in published pricing, or as a result of an inquiry to the help desk.
  • Code 4: The NADAC was carried forward from the previous file.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.


Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: July 08, 2026